In March, thirty-nine medical products underwent label revisions, with changes to the prescribing information to include any of the following areas: boxed warnings, contraindications, warnings, precautions, adverse reactions, patient package insert, and medication guide.
The following medications have been affected:
- Atacand HCT
- Kombiglyze XR
- Lidocaine in 5% Dextrose Injection
The attorneys of Jones Ward PLC represent hundreds of persons all across the country who have been injured by defective products, prescription drugs and medical devices. If you have any questions about one of the above prescription drugs and the ramifications of a drug label change, contact attorney Terrance Massey. You can reach him by phone at (502) 882-6000 or by email at email@example.com.